Food and Drug Administration

Cardiovascular & Renal Drugs Advisory Committee

May 29, 2003


ECG Studies Assessing Alfuzosin HCI Cardiac Repolarization Potential, Alfuzosin: alpha-1 blocker for benign prostatic hyperplasia, Sanofi-Synthelabo Research (HTM) (PPT)

Levitra® Tablets (NDA 21-400) (vardenafil HCI), Mary Taylor, MPH, Bayer (HTM) (PPT)

FDA Presentation, Drs. Griebel, MD, Jarugula, PhD, & Kenna. PhD (HTM) (PPT)

Open Public Hearing

Viagra (sildenafil citrate): Extensive Clinical and Post-Marketing Experience, Dr. Michael Sweeney, MD, Pfizer, Inc. (HTM) (PPT)